Internal Server Error

Theradaptive - About the company

Theradaptive is a series B company based in Boston (United States), founded in 2004 by Luis Alvarez. It operates as a Developer of protein engineering technology creating targeted therapeutics for tissue repair. Theradaptive has raised $50M in funding. The company has 173 active competitors, including 52 funded and 36 that have exited. Its top competitors include companies like Ossio, RevBio and MiMedx Group.

Company Details

Developer of protein engineering technology creating targeted therapeutics for tissue repair. The company focuses on improving therapeutic delivery to enhance efficacy and reduce off-target side effects. It has developed material binding variants of recombinant proteins for clinical indications. These modified proteins enable safer and long-term delivery for vascular, soft tissue, and orthopedic repair.
Email ID
*****@theradaptive.com
Phone Number
+1 **********
Registered Address
Lexington, Massachusetts
Key Metrics
Founded Year
2004
Location
Boston, United States
Stage
Series B
Total Funding
$50M in 7 rounds
Latest Funding Round
Investors
Ranked
Employee Count
40 as on Aug 31, 2026
Similar Companies
Sign up to download Theradaptive's company profile

Theradaptive's funding and investors

Theradaptive has raised a total funding of $50M over 7 rounds. Its first funding round was on 2018. Theradaptive has 6 institutional investors.

Here is the list of recent funding rounds of Theradaptive:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jul 21, 2026
1803481
Series B
2663599
4324849
6933524
7571027
May 22, 2024
6758103
Grant (prize money)
6202316
2859390
6356733
Jul 06, 2023
8173466
Grant (prize money)
3898967
8263135
6882616
lockAccess funding benchmarks and valuations. Sign up today!

Theradaptive's founders and board of directors

Founder? Claim Profile
The founders of Theradaptive is Luis Alvarez.
Here are the details of Theradaptive's key team members:

Theradaptive's employee count trend

Theradaptive has 40 employees as of Aug 26. Here is Theradaptive's employee count trend over the years:
Employee count trend for Theradaptive
lockUncover Theradaptive's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Theradaptive's Competitors and alternates

Top competitors of Theradaptive include Ossio, RevBio and MiMedx Group. Here is the list of Top 10 competitors of Theradaptive, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Ossio
Ossio
2014, Caesarea (Israel), Series C
Bone regeneration biocomposite
$89M
64/100
2nd
Logo for RevBio
RevBio
2014, Lowell (United States), Series B
Developer of synthetic adhesive used for bone/dental repair
$27.5M
63/100
3rd
Logo for Theradaptive
Theradaptive
2004, Boston (United States), Series B
Developer of protein engineering technology creating targeted therapeutics for tissue repair
$50M
61/100
4th
Logo for MiMedx Group
MiMedx Group
1985, Marietta (United States), Public
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
-
61/100
5th
Logo for Biocomposites
Biocomposites
1999, Keele (United Kingdom), Early Stage
Developer of synthetic calcium composite products for bone repair and regeneration
$1.8M
59/100
6th
Logo for Cerapedics
Cerapedics
1996, Westminster (United States), Series D
Developer of Osteobiologic products
$88.5M
58/100
7th
Logo for Regentis Biomaterials
Regentis Biomaterials
2004, Or Akiva (Israel), Public
Biodegradable hydrogels for tissue regeneration.
$25M
58/100
8th
Logo for Intersect ENT
Intersect ENT
2003, Menlo Park (United States), Acquired
Developer of drug releasing implant to treat sinusitis
$76.5M
54/100
9th
Logo for Re-Vana Therapeutics
Re-Vana Therapeutics
2015, Belfast (United Kingdom), Series A
Developer of drug delivery platform forophthalmic diseases
$20M
54/100
10th
Logo for Serigen
Serigen
2015, Pune (India), Seed
Develops silk protein-based biomedical products for tissue regeneration and healing
$3.63M
53/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Theradaptive's competitors? Click here to see the top ones

Theradaptive's Investments and acquisitions

Theradaptive has made no investments or acquisitions yet.

Reports related to Theradaptive

Here is the latest report on Theradaptive's sector:

News related to Theradaptive

lockFilter this list
Media has covered Theradaptive for a total of 2 events in the last 1 year, 1 of them has been about partnerships.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Theradaptive

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford